Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats

Journal of Neuropathology and Experimental Neurology

Volumn 65, Issue 10, 2006, Pages 945-952

  Zhao, Ping ^a   Huang, Yueming ^a   Zuo, Zhiyi ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Brain ischemia; Neuroprotection; Opioid receptors; Opioids; Preconditioning

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 7 BENZYLIDENENALTREXONE; BETA FUNALTREXAMINE; BINALTORPHIMINE; DELTA OPIATE RECEPTOR; GLUCOSE; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EXPOSURE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; FUNCTIONAL ASSESSMENT; HIPPOCAMPUS; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL NECROSIS; NERVOUS SYSTEM FUNCTION; NEUROPROTECTION; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANIMALS; BRAIN; BRAIN ISCHEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MORPHINE; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; TIME FACTORS;

EID: 33749471577     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jnen.0000235123.05677.4b     Document Type: Article

References (30)

1. Martin JA, Smith BL, Matthews TJ, Ventura SJ. Births and deaths: Preliminary data for 1998. Natl Vital Stat Rep 1999;47:1-45
2. Barry U, Zuo Z. Opioids: Old drugs for potential new applications. Current Pharmaceutical Design 2005;11:1343-50
3. Minami M, Satoh M. Molecular biology of the opioid receptors: Structures, functions and distributions. Neurosci Res 1995;23:121-45
4. Zhang J, Gibney GT, Zhao P, Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol Cell Physiol 2002;282:C1225-34
5. Zhang J, Haddad GG, Xia Y. Delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res 2000;885:143-53
6. Liang BT, Gross GJ. Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ Res 1999;84:1396-400
7. Wu S, Li HY, Wong TM. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ Res 1999;84:1388-95
8. Fryer RM, Hsu AK, Eells JT, et al. Opioid-induced second window of cardioprotection: Potential role of mitochondrial KATP channels. Circ Res 1999;84:846-51
9. Kodani E, Xuan YT, Shinmura K, et al. Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits. Am J Physiol Heart Circ Physiol 2002;283:H1943-57
10. Lim YJ, Zheng S, Zuo Z. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions. Anesthesiology 2004;100:562-68
11. Sullivan BL, Leu D, Taylor DM, et al. Isoflurane prevents delayed cell death in an organotypic slice culture model of cerebral ischemia. Anesthesiology 2002;96:189-95
12. Gross GJ. Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol 2003;35:709-18
13. Lever JR, Scheffel U. Selective in vivo binding of [3H]naltriben to delta-opioid receptors in mouse brain. Eur J Pharmacol 1998;350:335-44
14. Takemori AE, Larson DL, Portoghese PS. The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. Eur J Pharmacol 1981;70:445-51
15. Portoghese PS, Lipkowski AW, Takemori AE. Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sci 1987;40:1287-92
16. Raval AP, Dave KR, Mochly-Rosen D, et al. Epsilon PKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippocampal slice. J Neurosci 2003;23:384-91
17. Zheng S, Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of p38 mitogen-activated protein kinase. Mol Pharmacol 2004;65:1172-80
18. Belayev L, Alonso OF, Busto R, et al. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 1996;27:1616-22; discussion 23
19. Swanson RA, Morton MT, Tsao-Wu G, et al. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990;10:290-93
20. Rogers DC, Campbell CA, Stretton JL, Mackay KB. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 1997;28:2060-65
21. Rubaj A, Gustaw K, Zgodzinski W, et al. The role of opioid receptors in hypoxic preconditioning against seizures in brain. Pharmacol Biochem Behav 2000;67:65-70
22. Ammon-Treiber S, Stolze D, Schroder H, et al. Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model. Neuropharmacology 2005;49:1160-69
23. Arends RH, Hayashi TG, Luger TJ, Shen DD. Cotreatment with racemic fenfluramine inhibits the development of tolerance to morphine analgesia in rats. J Pharmacol Exp Ther 1998;286:585-92
24. Fryer RM, Hsu AK, Gross GJ. ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol 2001;96:136-42
25. Ma D, Hossain M, Chow A, et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005;58:182-93
26. Zhao P, Zuo Z. Isoflurane preconditioning induces neuroprotection that is inducible nitric oxide synthase-dependent in the neonatal rats. Anesthesiology 2004;101:695-702
27. Simons SH, van Dijk M, van Lingen RA, et al. Routine morphine infusion in preterm newborns who received ventilatory support: A randomized controlled trial. JAMA 2003;290:2419-27
28. Anand KJ, Barton BA, McIntosh N, et al. Analgesia and sedation in preterm neonates who require ventilatory support: Results from the NOPAIN trial. Neonatal Outcome and Prolonged Analgesia in Neonates. Arch Pediatr Adolesc Med 1999;153:331-38
29. Anand KJ, Hall RW, Desai N, et al. Effects of morphine analgesia in ventilated preterm neonates: Primary outcomes from the NEOPAIN randomised trial. Lancet 2004;363:1673-82
30. Angeles DM, Wycliffe N, Michelson D, et al. Use of opioids in asphyxiated term neonates: Effects on neuroimaging and clinical outcome. Pediatr Res 2005;57:873-78